Department of Adapted Physical Activity and Sport, Chair of Physiotherapy, School of Health Sciences in Katowice, Medical University of Silesia, 40-055 Katowice, Poland.
Department of Neurology, School of Medicine in Katowice, Medical University of Silesia, 40-055 Katowice, Poland.
Medicina (Kaunas). 2020 Mar 7;56(3):117. doi: 10.3390/medicina56030117.
The main arguments in support of researching anxiety and depression in patients with chronic somatic diseases are the prevalence of affective disorders in the population, somatic conditions as risk factors of affective disorders and the search for effective preventative and therapeutic strategies. The aim of the study was to determine the association between the functional status, selected sociodemographic characteristics and prevalence as well as severity of anxiety and depression in patients with multiple sclerosis (MS), Parkinson's disease (PD) and history of stroke (S). Eighty participants (44 women and 36 men) with MS ( = 22), PD ( = 31) and history of stroke ( = 27) were enrolled. All participants completed a questionnaire consisting of metrics, the Katz Index of Independence in Activities of Daily Living and the Hospital Anxiety and Depression Scale (HADS). Fifty-five per cent of all participants did not present with anxiety or depression, 20% scored above the diagnostic threshold on the anxiety scale and 26% scored above the diagnostic threshold on the depression scale. Subgroup analysis revealed that anxiety and depression sufferers were 13.64% and 13.64% of MS patients, respectively; 22.58% and 35.48% of PD patients, respectively; and 22.22% and 25.93% of stroke survivors, respectively. There was a significant correlation between depression and independence level in the entire group and between depression and marital status in stroke survivors. Although depression and anxiety are highly prevalent in patients with neurological conditions, the disorder has a very individual nature and is not associated with the patient's age, duration of a condition or concomitant diseases. Screening for depression and anxiety as a part of comprehensive approach may increase treatment efficacy in neurological patients.
情感障碍在人群中的普遍性、躯体状况是情感障碍的危险因素以及寻找有效预防和治疗策略的必要性。本研究的目的是确定多发性硬化症（MS）、帕金森病（PD）和中风史（S）患者的功能状态、某些社会人口统计学特征与焦虑和抑郁的患病率和严重程度之间的关联。 共有 80 名参与者（44 名女性和 36 名男性）入组，其中包括 MS（=22）、PD（=31）和中风史（=27）患者。所有参与者都完成了一份包含计量表、Katz 日常生活活动独立性指数和医院焦虑和抑郁量表（HADS）的问卷。 所有参与者中，55%没有表现出焦虑或抑郁，20%在焦虑量表上的得分超过诊断阈值，26%在抑郁量表上的得分超过诊断阈值。亚组分析表明，焦虑和抑郁患者分别占 MS 患者的 13.64%和 13.64%，PD 患者的 22.58%和 35.48%，中风幸存者的 22.22%和 25.93%。在整个组中，抑郁与独立性水平之间存在显著相关性，在中风幸存者中，抑郁与婚姻状况之间存在显著相关性。 尽管在患有神经系统疾病的患者中，抑郁和焦虑非常普遍，但这种疾病具有非常个体化的性质，与患者的年龄、疾病持续时间或合并症无关。对抑郁和焦虑进行筛查作为综合治疗的一部分可能会提高神经系统疾病患者的治疗效果。
